
Results
2
2 companies
Starpharma Holdings
Market Cap: AU$299.0m
A biopharmaceutical company, engages in the research, development and commercialization of dendrimer technology for pharmaceutical, healthcare applications, life science, and other applications in Australia and internationally.
SPL
AU$0.71
7D
2.9%
1Y
671.7%
Neuren Pharmaceuticals
Market Cap: AU$2.1b
A biopharmaceutical company, develops drugs for the treatment of neurological disorders.
NEU
AU$17.00
7D
33.2%
1Y
19.7%